Levetiracetam
Product Images NDC 67046-420

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 67046-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 6.jpg (Figure 5.jpg.jpg.jpg.jpg)

This is a chart showing the percentage of patients for two different treatments: Placetio (N=51) and Levetiracetam (N=58). However, the chart is incomplete and there are no labels on the y-axis.*

FDA Label Image

Levetiracetam Tablets 500mg 120 Ct Label (Rev 04/17)

This is a package insert for a medication called Levetiracetam with a usual dosage of 500 MG TAB #30. The packaging is blue and contains 30 film-coated tablets with the identification pill code of LU X02. The medication is to be stored at 25°C (77°F) and can have excursions permitted to 15-30°C (58-86°F) and is only available through prescription (Rx Only). The lot number is H400238 and the expiration date is 01/14/15. The medication is packaged by Contract Pharmacy Services-PA at their location in Warrnaton, PA, with NDC code 67046-420-30.*

FDA Label Image

Image 0 (Levetiracetamtabletscombi Figure 01)

This text provides a formula to calculate the total daily dose of a medication for a patient based on their weight and the recommended daily dose in milligrams per kilogram. The medication is provided in a concentration of 100 milligrams per milliliter.*

FDA Label Image

Image 1 (Levetiracetamtabletscombi Figure 02)

This text presents a formula to calculate CLer (clearance of creatinine), a measure of kidney function, in female patients. The formula takes into account the patient's age, weight, and serum creatinine levels. CLer is then adjusted for body surface area.*

FDA Label Image

Image 2 (Levetiracetamtabletscombi Figure 03)

FDA Label Image

Image 3 (Levetiracetamtabletscombi Figure 04)

FDA Label Image

Image 4 (Levetiracetamtabletscombi Figure 05)

This appears to be a table showing the percentage of patients in different treatment groups (Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day) and their corresponding response rates. The response rates are given as percentages ranging from 0% to 35.2%.*

FDA Label Image

Image 5 (Levetiracetamtabletscombi Figure 06)

FDA Label Image

Image 6 (Levetiracetamtabletscombi Figure 07)

This is a statistical data table showing the percentage breakdown of patients involved in a treatment study for a medication called Levetiracetam compared to a placebo group. There are different patient percentages listed under each column and row, but there is not enough information to determine what the percentages represent.*

FDA Label Image

Image 7 (Levetiracetamtabletscombi Figure 08)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.